Cherry Bekaert’s dedicated team of transaction professionals has assisted healthcare clients in every aspect of strategic and financial deals from start to finish, including buy-side and sell-side due diligence, pre-deal valuation services and post-deal purchase price allocations, as well as related valuation services. Our Transactions team has undertaken deals with total transaction values in excess of $126 billion. This established track record combined with the knowledge and expertise gained in middle market transactions makes the Firm an ideal partner for any transaction project.
Healthcare & Life Sciences Transaction Experience
Cherry Bekaert’s National Healthcare & Life Sciences Transactions Practice is uniquely positioned at the intersection of our Private Equity and Healthcare & Life Sciences practices. This means your Cherry Bekaert Healthcare & Life Sciences Transactions team not only has extensive deal experience, but also possess in-depth expertise of the healthcare and life sciences industries. As a result, we enhance the efficiency and value of every healthcare transaction at each stage of the deal with our industry-unique 100% healthcare & life sciences/private equity led team!